Zobrazeno 1 - 10
of 128
pro vyhledávání: '"James W. Fisher"'
Publikováno v:
International Journal of Cognitive Therapy. 9:1-12
The concept of cognitive bias is embedded in cognitive-behavioral theorizing, and treatment, of depression. Moore and Fresco (2007) were the first to examine this issue in the context of the etiology of depression by studying the accuracy of attribut
Autor:
Dennis M. Gross, George M. Rodgers, William J. George, Peter Kim Nelson, William Jubiz, James E. Foley, James W. Fisher
Our hypothesis is that PGs released within the kidney play a role in the modulation of kidney production of Ep. PGs release probably at medullary and/or cortical sites following erythropoietic stimuli such as hypoxic hypoxia, anemic hypoxia, and isch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c51b42fce4afa1212fe21255c6194322
https://doi.org/10.1159/000402133
https://doi.org/10.1159/000402133
Publikováno v:
Life Sciences. 63:523-535
Some investigators have reported previously that phorbol esters inhibit in vitro erythropoietin production stimulated by hypoxia; whereas others have reported that phorbol esters enhanced Epo production during exposure to hypoxia. We have demonstrate
Autor:
James W. Fisher
Publikováno v:
Experimental Biology and Medicine. 216:358-369
The purpose of this review is to give an update of the recent progress in research on erythropoietin (Epo), the hormone that regulates red blood cell production. Epo is a glycoprotein with a molecular mass of approx 30 kDa, which circulates in plasma
Publikováno v:
Life Sciences. 58:421-427
We have previously reported that a marked increase in erythropoietin (Epo) production can be demonstrated in Hep3B cell cultures in response to hypoxia (1). In order to determine whether this increase involves an autocrine mechanism, we have investig
Autor:
James W, Fisher
Publikováno v:
Journal (Indiana Dental Association). 91(1)
Publikováno v:
American Journal of Physiology-Cell Physiology. 265:C934-C938
N6-cyclopentyladenosine (CPA), a selective adenosine A1 receptor agonist, in a concentration range of 10(-9) to 10(-7) M, produced a significant decrease in erythropoietin (EPO) levels in a human hepatocellular carcinoma (Hep G2) cell culture (medium
Publikováno v:
Journal of Clinical Investigation. 92:1587-1591
The present study was designed to investigate whether in vivo and in vitro erythropoietin (EPO) production is modulated by nitric oxide (NO) and cyclic guanosine 3',5'-monophosphate (cGMP). Serum levels of EPO in ex-hypoxic polycythemic mice were sig
Autor:
James W. Fisher
Publikováno v:
Experimental biology and medicine (Maywood, N.J.). 235(12)
This is a Minireview covering landmarks or milestones in the development of erythropoietin (EPO). Thirty-nine landmark advances have been identified, which cover the period 1863–2003. Several reports are included that directly support these origina